简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-06-30 14:03 Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour
2026-06-30 11:19 Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station
2026-06-30 11:02 Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)
2026-06-29 13:43 Amazfit Brings Interactive iOS Notifications to Select Smartwatches in Europe
2026-06-29 13:15 Burjeel Holdings Prices First MENA Healthcare Sukuk Since 2018, 3.2x Oversubscribed
2026-06-29 13:10 DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
2026-06-26 11:28 MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b
2026-06-26 11:05 New MetLife Study Reveals a 72% “Confidence Gap” in Ability to Recover from Life's Setbacks
2026-06-24 15:14 Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO
2026-06-24 10:11 Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
2026-06-23 11:51 HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors
2026-06-23 11:08 Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training
2026-06-18 12:02 AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
2026-06-16 11:38 New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
2026-06-16 11:18 Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery
2026-06-16 10:40 SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
2026-06-15 12:28 BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
2026-06-15 10:53 BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
2026-06-12 14:35 Merrithew® Expands Global Mindful Movement Leadership with Acquisition of the GYROTONIC® Organization
2026-06-12 09:44 Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Business Wire Weibo

Press Releases

Latest Releases